Corporate Updates

GlaxoSmithKline eyes new acquisitions in India

Views: 2.6K

Global pharma giant GlaxoSmithKline is eyeing acquisitions worth $ 2 billion in India, the world’s fastest-growing drug market, media reports said.
“India is clearly on the radar. We plan to spend between $ 500 million and $ 2 billion. I would love to buy something in India,” GSK Chief Executive Andrew Witty told.

GSK, which employs 5,000 people and has turnover of more than $ 1 billion in India, was, however, unlikely to pursue large-scale merger and acquisitions, and was unwilling to overpay for companies.



  1. Very informative article.Really looking forward to read more. Really Great.

  2. sell your website

    April 20, 2018 at 11:25 pm

    I really enjoy the article. Really Cool.

  3. pozycjonowanie gorzow

    April 22, 2018 at 12:47 am

    you’re in reality a just right webmaster. The web site loading speed is incredible. It kind of feels that you are doing any distinctive trick. Moreover, The contents are masterpiece. you have done a excellent job on this topic!

  4. tri-cities real estate

    April 22, 2018 at 6:43 pm

    Enjoyed every bit of your article post. Fantastic.

  5. cheap air

    April 23, 2018 at 4:03 am

    I¡¦ve recently started a web site, the info you offer on this site has helped me greatly. Thanks for all of your time & work.

  6. bali tour

    April 24, 2018 at 4:48 pm

    I have been absent for a while, but now I remember why I used to love this web site. Thanks , I will try and check back more frequently. How frequently you update your site?

Leave a Reply

Your email address will not be published.

Most Popular





Get Heard Portal


eHealth Event Report



To Top